News
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...
The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results